The total return over the past 12 months is -76.55% vs. +16.94% for the S&P 500. So far it's up -29.74% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | (76.55%) | (65.82%) | (52.99%) | N/A | N/A | N/A |
| Total Return CAGR | (76.55%) | (65.82%) | (52.99%) | N/A | N/A | N/A |
| Revenue CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Income CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| EPS CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
enVVeno Medical Corporation (NVNO)
| Year | Start price | End price | NVNO Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $11.40 | $8.01 | (29.74%) | +14.51% | (44.25%) |
| 2025 | $107.29 | $11.40 | (89.37%) | +17.72% | (107.09%) |
| 2024 | $182.60 | $107.29 | (41.24%) | +24.89% | (66.13%) |
| 2023 | $181.18 | $182.60 | +0.78% | +26.19% | (25.41%) |
| 2022 | $234.11 | $181.18 | (22.61%) | (18.17%) | (4.44%) |
| 2021 | $307.29 | $234.11 | (23.81%) | +28.74% | (52.55%) |
| 2020 | $488.47 | $307.29 | (37.09%) | +18.37% | (55.46%) |
| 2019 | $1,310.16 | $488.47 | (62.72%) | +31.22% | (93.94%) |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
